Scholarly Index
Sabine C. Linn
The Netherlands Cancer Institute; 17,268 total citations; 380 total publications; best world rank #276
The Netherlands Cancer Institute
17,268Total citations
380Total publications
65H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Breast Cancer Treatment Studies | Lifetime | 425 | NL 17 | 98.72 |
| HER2/EGFR in Cancer Research | Lifetime | 398 | NL 10 | 98.30 |
| Advanced Breast Cancer Therapies | Lifetime | 319 | NL 5 | 97.41 |
| BRCA gene mutations in cancer | Lifetime | 829 | NL 37 | 95.27 |
| PARP inhibition in cancer therapy | Lifetime | 522 | NL 12 | 94.38 |
| Breast Cancer Treatment Studies | 2021-2025 | 507 | NL 21 | 94.56 |
| BRCA gene mutations in cancer | 2021-2025 | 428 | NL 13 | 89.61 |
| Advanced Breast Cancer Therapies | 2021-2025 | 614 | NL 8 | 88.80 |
| HER2/EGFR in Cancer Research | 2021-2025 | 738 | NL 15 | 88.37 |
| Multiple and Secondary Primary Cancers | 2021-2025 | 276 | NL 11 | 83.30 |
| Cancer Treatment and Pharmacology | 2021-2025 | 820 | NL 15 | 85.64 |
| Cancer Risks and Factors | 2021-2025 | 584 | NL 20 | 81.19 |
| Estrogen and related hormone effects | 2021-2025 | 581 | NL 18 | 77.70 |